242 related articles for article (PubMed ID: 31195244)
1. Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.
Heffner JL; Evins AE; Russ C; Lawrence D; Ayers CR; McRae T; Aubin LS; Krishen A; West R; Anthenelli RM
J Affect Disord; 2019 Sep; 256():267-277. PubMed ID: 31195244
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial.
Ayers CR; Heffner JL; Russ C; Lawrence D; McRae T; Evins AE; Anthenelli RM
Depress Anxiety; 2020 Mar; 37(3):247-260. PubMed ID: 31850603
[TBL] [Abstract][Full Text] [Related]
4. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
Cinciripini PM; Kypriotakis G; Green C; Lawrence D; Anthenelli RM; Minnix J; Blalock JA; Beneventi D; Morris C; Karam-Hage M
Depress Anxiety; 2022 May; 39(5):429-440. PubMed ID: 35535436
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE
Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918
[TBL] [Abstract][Full Text] [Related]
6. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.
Evins AE; Benowitz NL; West R; Russ C; McRae T; Lawrence D; Krishen A; St Aubin L; Maravic MC; Anthenelli RM
J Clin Psychopharmacol; 2019; 39(2):108-116. PubMed ID: 30811371
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES.
Evins AE; West R; Benowitz NL; Russ C; Lawrence D; McRae T; Maravic MC; Heffner JL; Anthenelli RM
Psychiatr Serv; 2021 Jan; 72(1):7-15. PubMed ID: 33138708
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cahill K; Stevens S; Perera R; Lancaster T
Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
Anthenelli RM; Gaffney M; Benowitz NL; West R; McRae T; Russ C; Lawrence D; St Aubin L; Krishen A; Evins AE
J Gen Intern Med; 2019 Jun; 34(6):862-870. PubMed ID: 30847828
[TBL] [Abstract][Full Text] [Related]
11. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
12. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
13. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants for smoking cessation.
Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
[TBL] [Abstract][Full Text] [Related]
15. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
16. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
17. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for promoting smoking cessation during pregnancy.
Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
Cochrane Database Syst Rev; 2015 Dec; (12):CD010078. PubMed ID: 26690977
[TBL] [Abstract][Full Text] [Related]
19. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for promoting smoking cessation during pregnancy.
Claire R; Chamberlain C; Davey MA; Cooper SE; Berlin I; Leonardi-Bee J; Coleman T
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010078. PubMed ID: 32129504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
